CORONA Remedies Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Press Release - Receipt of EU-GMP Certificate".
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Corona Remedies has received EU-GMP Compliance Certification for its Hormone manufacturing facility and renewed EU-GMP approval for its Oral Solid Dosage (OSD) facility at Bhayla, Ahmedabad. The certifications follow an EUDRA GMP inspection conducted in April 2026. This accreditation enables the company to serve both Indian and regulated/semi-regulated global markets from these facilities, particularly expanding its Hormone portfolio internationally. The company positioned this as a milestone under its 'One World. One Quality' philosophy.
EU-GMP certification opens doors to regulated markets like the EU, potentially boosting future export revenue and strengthening the company's global manufacturing credibility in hormone and oral solid dosage segments.